ULTRALIFE CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $191.2M | $164.5M | $158.6M | $131.8M | $98.3M |
| Gross profit | $46.0M | $42.3M | $39.2M | $29.4M | $24.6M |
| Operating income | -$5.9M | $10.0M | $9.5M | $129,000 | $35,000 |
| Operating expenses | $51.9M | $32.3M | $29.7M | $29.3M | $24.6M |
| Cost of revenue | $145.1M | $122.1M | $119.4M | $102.4M | $73.6M |
| Cash from operations | $11.0M | $16.6M | $1.9M | -$1.3M | $4.3M |
| Capital expenditure | $3.9M | $1.9M | $2.6M | $1.7M | $2.8M |
| Free cash flow | $7.1M | $14.7M | -$623,000 | -$2.9M | $1.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $216.9M | $220.5M | $178.3M | $168.4M | $159.5M |
| Total liabilities | $86.8M | $86.3M | $52.8M | $52.0M | $41.8M |
Shares outstanding 16.7M · Free float 17.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.